Industry Expertise

Product and Portfolio Strategy

Developing, launching, and managing medical products can be fraught with opportunity and risk. The complex web of stakeholders – patients, physicians, payers, competitors, channel partners, suppliers, regulatory agencies, etc. – creates challenges to managing product and portfolio performance. As competition increases and windows of exclusivity shrink, medical sciences companies face greater pressure to manage these challenges and deliver results with each product opportunity.

Kaiser Associates helps clients in the medical sciences industry fully capitalize on product opportunities, navigate the environment with greater certainty, and maximize the lifetime commercial value of its portfolio. Kaiser conducts comprehensive primary research and analyses at all stages of the product lifecycle to inform the decision making of sales and marketing executives. Kaiser's approach establishes the required fact base to vet the critical decisions and brings together data from disparate sources to develop holistic strategies.

Kaiser supports upstream and downstream marketing executives across all stages of the product lifecycle.

Kaiser Experience:


 Early Development
  Late Stage
  Development

  Product Launch
  Lifecycle
  Management

 End of Life
  • Market Sizing
  • Patient flow analysis
  • Competitive Landscape Analysis
  • Product profile optimization
    (conjoint analysis / choice modeling)
  • Buy vs. build vs.
    partner analysis
  • Detailed voice of customer analysis
  • Product forecasting
  • Thought leader strategy / medical marketing plan
  • Competitive
    Positioning
  • Pricing /
    reimbursement analysis
  • Customer Segmentation Analysis
  • Customer Messaging
  • Referral network development
  • Forecast sensitivity analysis
  • Service and education requirements
  • Competitor response planning / wargaming
  • Revenue & profit management
  • Deployment models
  • Competitive offense strategy
  • Sales force effectiveness
  • New indication and line Extension planning
  • International launch planning
  • Patent expiration / generic defense planning
  • End of Life Evaluation and Planning
  • Conversion / upgrade strategies
  • Resource reallocation